News | July 28, 2023
Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
Dr. Lal Path Labs Ltd. has reported total income of Rs. 555.4 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Jubilant Ingrevia has reported total income of Rs. 1083.52 crores during the period ended June 30, 2023
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
Subscribe To Our Newsletter & Stay Updated
